GTP Bioways teams are excited to take part in the BioTrinity on April 25-26!
BioTrinity is a must-attend event in London, that catalyses growth and support engagement across the life-science industry. The conference is attended by emerging life science R&D companies, investors, big pharma, and other major partners in the life science ecosystem.
The program is rich and simulating, focusing on eight core therapies areas: Oncology, Neuroscience, Microbiome, Inflammatory Diseases, Rare Diseases, Infectious Diseases, Medtech and Cell & Gene Therapy.
The sessions promise to be of the highest quality, with great speakers bringing their knowledge and expertise.
Partnering meetings will be hold during the two days to discuss investable opportunities and collaboration possibilities between peers.
We would be more than pleased to meet you there to learn on your next developments and introduce our expert & flexible biologics CDMO services. We can provide flexible capacities for the process development of your biologics and for the supply of pre-clinical and clinical batches of any protein type, in microbial or mammalian expression systems.
Don’t hesitate to schedule a meeting with Mélusine Larivière, Business Development Manager at GTP Bioways, who will attend the event.
Contact Mrs. Mélusine Larivière to schedule a meeting.